Skip to main navigation Skip to search Skip to main content

WAVE T1D: A Randomized Phase I/II Trial of Low Dose Anti-thymocyte Globulin (ATG) with Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes (WAVE T1D)

    Project: Research

    Project Details

    StatusActive
    Effective start/end date11/25/25 → …